References
- Nielsen H, Hansen KK, Gradel KO, et al. Bacteraemia as a result of Campylobacter species: a population-based study of epidemiology and clinical risk factors. Clin Microbiol Infect. 2010;16:57–61.
- Allos BM. Campylobacter jejuni infections: update on emerging issues and trends. Clin Infect Dis. 2001;32:1201–1206.
- Butzler JP. Campylobacter, from obscurity to celebrity. Clin Microbiol Infect. 2004;10:868–876.
- Pacanowski J, Lalande V, CAMPYL Study Group, et al. Campylobacter bacteremia: clinical features and factors associated with fatal outcome. Clin Infect Dis. 2008;47:790–796.
- Guerrant RL, Lahita RG, Winn WC, Jr., et al. Campylobacteriosis in man: pathogenic mechanisms and review of 91 bloodstream infections. Am J Med. 1978;65:584–592.
- Fernandez-Cruz A, Munoz P, Mohedano R, et al. Campylobacter bacteremia: clinical characteristics, incidence, and outcome over 23 years. Medicine (Baltimore). 2010;89:319–330.
- Schonheyder HC, Sogaard P, Frederiksen W. A survey of Campylobacter bacteremia in three Danish counties, 1989 to 1994. Scand J Infect Dis. 1995;27:145–148.
- Samuel MC, Vugia DJ, Emerging Infections Program FoodNet Working Group, et al. Epidemiology of sporadic Campylobacter infection in the United States and declining trend in incidence, FoodNet 1996–1999. Clin Infect Dis. 2004;38:S165–S174.
- Reed RP, Friedland IR, Wegerhoff FO, et al. Campylobacter bacteremia in children. Pediatr Infect Dis J. 1996;15:345–348.
- Pigrau C, Bartolome R, Almirante B, et al. Bacteremia due to Campylobacter species: clinical findings and antimicrobial susceptibility patterns. Clin Infect Dis. 1997;25:1414–1420.
- Wang G, Clark CG, Taylor TM, et al. Colony multiplex PCR assay for identification and differentiation of Campylobacter jejuni, C. coli, C. lari, C. upsaliensis, and C. fetus subsp. fetus. J Clin Microbiol. 2002;40:4744–4747.
- Weinberger M, Lerner L, Valinsky L, et al. Increased incidence of Campylobacter spp. Infection and high rates among children, Israel. Emerging Infect Dis. 2013;19:1828–1831.
- Tremblay C, Gaudreau C, Lorange M. Epidemiology and antimicrobial susceptibilities of 111 Campylobacter fetus subsp. fetus strains isolated in Québec, Canada, from 1983 to 2000. J Clin Microbiol. 2003;41:463–466.
- Tajada P, Gomez-Garces JL, Alos JI, et al. Antimicrobial susceptibilities of Campylobacter jejuni and Campylobacter coli to 12 b-lactam agents and combination with b-lactamase inhibitors. Antimicrob Agents Chemother. 1996;40:1924–1925.
- Tremblay C, Gaudreau C. Antimicrobial susceptibility testing of 59 strains of Campylobacter fetus subsp. fetus. Antimicrob Agents Chemother. 1998;42:1847–1849.
- Lachance N, Gaudreau C, Lamothe F, et al. Role of the beta-lactamase of Campylobacter jejuni in resistance to beta-lactam agents. Antimicrob Agents Chemother. 1991;35:813–818.
- Sanz-Garcia M, Fernandez-Cruz A, Rodriguez-Creixems M, et al. Recurrent Escherichia coli bloodstream infections: epidemiology and risk factors. Medicine (Baltimore). 2009;88:77–82.
- Feodoroff B, Lauhio A, Ellstrom P, et al. A nationwide study of Campylobacter jejuni and Campylobacter coli bacteremia in Finland over a 10-year period, 1998–2007, with special reference to clinical characteristics and antimicrobial susceptibility. Clin Infect Dis. 2011;53:e99–106.
- Tee W, Mijch A. Campylobacter jejuni bacteremia in human immunodeficiency virus (HIV)-infected and non-HIV-infected patients: comparison of clinical features and review. Clin Infect Dis. 1998;26:91–96.
- Skirrow MB, Jones DM, Sutcliffe E, et al. Campylobacter bacteraemia in England and Wales, 1981-91. Epidemiol Infect. 1993;110:567–573.
- Blaser MJ. Campylobacter fetus-emerging infection and model system for bacterial pathogenesis at mucosal surfaces. Clin Infect Dis. 1998;27:256–258.
- Schmidt U, Chmel H, Kaminski Z, et al. The clinical spectrum of Campylobacter fetus infections: report of five cases and review of the literature. Q J Med. 1980;49:431–442.